The novel SARS-coronavirus 2 (SARS-CoV-2) which causes the disease COVID-19 has been shown to utilize the SARS-CoV receptor ACE2 for entry into human cells (Hoffman, M. et al., Cell 2020). The entry of a coronavirus into host cells is mediated by the vir
Clonality:
Polyclonal
Concentration:
Lot Dependent
Buffer:
PBS + 50% glycerol and 5 mm NaN3
Source:
Recombinant SARS-CoV-2 S-Protein construct containing the ACE2 binding domain expressed in and purified from E. coli.
Purity:
Antigen Affinity purification
Target:
SARS-CoV-2 S-Protein ACE2 Binding Domain
Application Dilute:
WB(1:300-5000)
* VAT and and shipping costs not included. Errors and price changes excepted
